Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Innovative Medicines for Cardiovascular Disease

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2T2M6lh
via IFTTT